On Wednesday, Molycorp Inc (NYSE:MCP)’s shares declined -6.89% to $0.517.
Molycorp Inc (MCP) declared financial and operating results for the first quarter of 2015.
FIRST QUARTER 2015 RESULTS
The Company stated merged net revenues of $106 million, an 8% decrease over the fourth quarter of 2014. The decrease in revenues was largely driven by a shifting product mix and softened pricing for rare earths, offset in part by raised volume.
During the first quarter of 2015, the Company sold 3,436 mt of product at an ASP of $30.97 per kilogram, generating a gross loss of $25 million. This compares to sales volumes of 3,149 mt at an ASP of $36.91 per kilogram and a gross loss of $45 million during the fourth quarter of 2014.
Molycorp stated a loss attributable to common stockholders of $102 million for the quarter, or $0.42 per share. An adjusted loss per share of $0.28 in the quarter does not reflect charges for impairment of inventory at Mountain Pass, out-of-ordinary business expenses, and certain other non-cash items.
The Company stated negative cash flows from operating activities of $73 million during the first quarter of 2015, and had $134 million in cash and cash equivalents as of March 31, 2015. During the three months ended March 31, 2015, Molycorp’s capital expenditures were $6 million on a cash basis.
Molycorp, Inc. produces and sells rare earths and rare metal materials in the United States and internationally. The company’s Resources segment extracts rare earth minerals, counting light rare earth concentrates; rare earth oxides (REO), such as lanthanum, cerium, and neodymium-praseodymium; heavy rare earth concentrates, which comprise samarium, europium, gadolinium, terbium, dysprosium, and others; and SorbX and PhosFIX, a line of rare earth-based water treatment products.
BioScrip Inc (NASDAQ:BIOS)’s shares dropped -5.79% to $3.74.
BioScrip Inc (BIOS) declared the commencement of an exchange offer following which it is offering to exchange up to $200,000,000 in aggregate principal amount of 8.875% Senior Notes due 2021 (the “Exchange Notes”), which have been registered under the Securities Act of 1933, as amended (the “Securities Act”), for an equal aggregate principal amount of its outstanding 8.875% Senior Notes due 2021 (the “Old Notes”) that were originally issued on February 11, 2014, in a transaction exempt from registration under the Securities Act. The terms of the Exchange Notes are substantially identical to the terms of the Old Notes, except that the Exchange Notes have been registered under the Securities Act and will not be subject to the transfer restrictions and registration rights that related to the Old Notes.
The exchange offer will expire at 5:00 p.m., New York City time, on June 9, 2015, unless extended. Tenders of Old Notes must be made before the exchange offer expires and may be withdrawn any time proceeding to the expiration of the exchange offer.
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit administration (PBM) services in the United States. It operates in two segments, Infusion Services and PBM Services.
At the end of Wednesday’s trade, Delta Air Lines, Inc. (NYSE:DAL)‘s shares dipped -5.60% to $43.62.
Delta Air Lines, Inc. (DAL) safety video is the best thing to happen to the Internet since the cloud. A mash-up of some of the Internet’s most-loved memes, the video brings together stars like Keyboard Cat, Dramatic Chipmunk, and a certain Screaming Goat with a penchant for pop music.
Charlie is still biting his brother’s finger, the Evolution of Dance evolves, Annoying Orange is – shockingly – still annoying and Overly Attached Girlfriend has her eye on someone new. Will It Blend Guy continues his noble quest to answer the age-old question – will it blend? Delta’s original Internet star also makes an appearance. Combined, the Internet personalities featured in the video have gathered nearly 2 billion views on the videos that made them famous.
Delta Air Lines serves more than 170 million customers each year. Delta was named to FORTUNE magazine’s top 50 World’s Most Admired Companies in addition to being named the most admired airline for the fourth time in five years. Additionally, Delta has ranked No.1 in the Business Travel News Annual Airline survey for four successive years, a first for any airline. With an industry-leading global network, Delta and the Delta Connection carriers offer service to 327 destinations in 60 countries on six continents. Headquartered in Atlanta, Delta employs nearly 80,000 employees worldwide and operates a mainline fleet of more than 700 aircraft.
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita.
Unilife Corp (NASDAQ:UNIS), ended its Wednesday’s trading session with -5.32% loss, and closed at $2.85.
Unilife Corp (UNIS) declared its financial results for the quarter ended March 31, 2015 (“the third quarter of Fiscal Year 2015″, “3Q FY15″ or “Current Quarter”).
Mr. Alan Shortall, Chairman and CEO of Unilife, commented: “Our strategy to build long-term, planned partnerships with pharmaceutical and biotechnology leaders continues to gather pace. In addition to a new partnership with a major pharmaceutical company revealed in January, partnership talk about also advanced favorably with a number of other companies seeking long-term access to our products and services. In parallel, we continue to broaden many existing customer relationships beyond their original scope as initial programs accelerate and additional programs get ready to commence.
Financial Results for Three Months Ended March 31, 2015
Revenue for the Current Quarter was $2.9 million, contrast to $1.4 million for the same period in the previous fiscal year. Cash receipts from customers were $8.9 million in the Current Quarter.
Since December 31, 2014, deferred revenue raised by $7.7 million to $24.8 million.
The Company’s net loss for the Current Quarter was $23.1 million, or $0.20 per share, contrast to a net loss of $15.1 million, or $0.15 per share, for the same period in the previous fiscal year. Adjusted net loss for the Current Quarter was $16.3 million, or $0.14 per share, contrast to $11.7 million, or $0.12 per share, for the same period in the previous fiscal year. This enhance in adjusted net loss is primarily attributable to raised investment in R&D. Adjusted net loss excludes $6.8 million of charges in the Current Quarter contrast to $3.4 million for the same period in the previous fiscal year. Adjusted net loss excludes non-cash share-based compensation expense, depreciation and amortization, interest expense and the change in fair value of financial instruments.
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
